| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/12/2019 | Vaxart, Inc. | VXRT | Grant | Stock Option (right to buy) | 9k | $0.68 | $6.1k | | 06/12/2019 |
| 06/12/2019 | Vaxart, Inc. | VXRT | Grant | Stock Option (right to buy) | 12.7k | $0.68 | $8.6k | | 06/12/2019 |
| 02/13/2018 | Vaxart, Inc. | VXRT | Grant | Common Stock | 30.8M | $0.00 | $0 | See Footnote | 02/13/2018 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series C Convertible Preferred Stock | 320.3k | $0.00 | $0 | By Care Capital Investments III, LP | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series B Convertible Preferred Stock | 20k | $0.00 | $0 | By Care Capital Offshore Investments III, LP | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series B Convertible Preferred Stock | 1.2M | $0.00 | $0 | By Care Capital Investments III, LP | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series C Convertible Preferred Stock | 5.4k | $0.00 | $0 | By Care Capital Offshore Investments III, LP | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Common Stock | 25.4k | $0.00 | $0 | By Care Capital Offshore Investments III, LP | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Common Stock | 1.5M | $0.00 | $0 | By Care Capital Investments III, LP | 05/11/2015 |
| 05/05/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Grant | Stock Option (Right to Buy) | 6k | $10.00 | $59.5k | | 05/05/2015 |
| 04/30/2015 | NephroGenex, Inc. | NRX | Grant | | 6.9k | $7.31 | $50.2k | | 04/30/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series C Convertible Preferred Stock | 5.4k | $0.00 | $0 | By Care Capital Offshore Investments III, LP | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series C Convertible Preferred Stock | 320.3k | $0.00 | $0 | By Care Capital Investments III, LP | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series B Convertible Preferred Stock | 16k | $0.00 | $0 | By Care Capital Offshore Investments III, LP | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series B Convertible Preferred Stock | 959.9k | $0.00 | $0 | By Care Capital Investments III, LP | 05/05/2015 |
| 05/15/2014 | NephroGenex, Inc. | NRX | Grant | Options to Purchase Common Stock | 3.1k | $11.90 | $36.6k | | 05/15/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Series A Preferred Stock | 5.8M | $0.00 | $0 | See footnote | 02/14/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Conversion | 8% Convertible Promissory Note | 0 | $0.00 | $0 | See footnote | 02/14/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Series A Preferred Stock | 14M | $0.00 | $0 | See footnote | 02/14/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Purchase | Common Stock | 790k | $12.00 | $9.5M | See footnote | 02/14/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Grant | Common Stock | 412.6k | $0.00 | $0 | See footnote | 02/14/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Common Stock | 890.1k | $0.00 | $0 | See footnote | 02/14/2014 |
| 02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Common Stock | 2.1M | $0.00 | $0 | See footnote | 02/14/2014 |